Renaissance Capital logo

US IPO Weekly Recap: IPO market returns from vacation with a 128% pop

September 14, 2018
Weekly Recap

The IPO market is back from its annual month-long break, with the first listings since mid-August. The hot money has come with it.

Despite a broad sell-off among China stocks, three Chinese companies priced US IPOs this week. All three priced at the low end of the range. News app Qutoutiao, meaning "Fun Headlines," made headlines on Friday when popped 128% - the best of the year - helped by a small float (~3% of market cap). Just as unusual, electric vehicle startup NIO (NIO) raised $1 billion and traded up 5% on its debut, popped 75% on its second day, and then pulled back 12% on its third. Online pharmacy 111 (YI) broke issue and finished down 5%.

Targeting cancers, autoimmune diseases, inflammation, Principia Biopharma (PRNB) priced an upsized offering at the high end. It popped 96%, the year's best pop for a biotech, and the 3rd-best overall. Rounding out the week, Washington, DC area bank FVCBankcorp (FVCB) raised $35 million in a Nasdaq IPO, and finished at its offer price.

Navios Maritime Containers LP (NMCI) postponed its $100 million IPO; the containership operator formed by Navios instead plans to pursue a direct listing. In addition, two companies officially withdrew stale US IPO filings: Petroleum tanker company Product Shipping Limited (PROS) and Guatemalan bank Bicapital (BICA).

The 2018 IPO market just hit a major milestone: this year's IPOs have raised $35.7 billion, more than the full-year 2017 ($35.5 billion). Year-to-date proceeds are 61% higher than this point last year.

In non-US news, China's Meituan Dianping (3690.HK) raised $4.2 billion in the year's fifth-largest global IPO (4/5 have been in China). Institutional investors track the non-US IPO market with IPO Intelligence.


5 IPOs During the Week of September 10th, 2018
Issuer
Business
Deal
Size
Market Cap
at IPO
Price vs.
Midpoint
First Day
Return
Return
at 09/14
Qutoutiao (QTT) $84M $2,105M -13% +128% +128%
China's second largest mobile content aggregator focusing on lower tier cities.
Principia Biopharma (PRNB) $106M $418M 6% +92% +92%
Developing oral small molecule therapies for pemphigus, ITP and MS.
NIO (NIO) $1,002M $6,886M -14% +5% +58%
China-based producer of high-performance electric vehicles.
FVCBankcorp (FVCB) $35M $257M 0% +0% +0%
Community bank serving Washington, DC and Northern Virginia.
111 (YI) $99M $1,212M -7% -1% +0%
Operates an online retail drugstore and healthcare platform in China.

Sign up for a free trial of our premium platform, IPO Pro. Follow us on Twitter (@IPOtweet) and register for our updates on the IPO market.



5 Filings During the Week of September 10th, 2018
Issuer
Business
Deal
Size
Sector Lead
Underwriter
Allogene Therapeutics (ALLO) $100M Health Care Goldman
Phase 1 biotech developing off-the-shelf CAR T cell cancer therapies.
ChaSerg Tech Acquisition (CTAC.U) $200M SPAC Cantor Fitz.
Blank check company formed by tech veterans to acquire a technology company.
Collier Creek (CCH.U) $350M SPAC Citi
Blank check company led by Pinnacle Foods Chairman Roger Deromedi.
ARYA Sciences Acquisition (ARYAU) $125M SPAC Jefferies
Blank check company formed by Perceptive Advisors to acquire a healthcare business.
EdtechX Acquisition (EDTXU) $55M SPAC Chardan
Blank check company formed by IBIS Capital to acquire an education technology business.